Odyssey Therapeutics Revenue

Biotechnology Research • United States • 101-200 Employees

Odyssey Therapeutics revenue & valuation

Annual revenue	$2,000,000
Revenue per employee	$17,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,400,000
Total funding	$314,000,000

Key Contacts at Odyssey Therapeutics

Kelly Bourdon

Sr. Director, Clinical Development Operations

Florian Schmidt

Co-Founder And Consultant

Felix Meiß

Co-Founder And Consultant

Camila Serna

Director Of Business Development & Alliance Management

Sebastian Kühner

Executive Director

Stephen Furlong

Director Aws Platform Engineering

Mustafa Varoglu

Sr. Director, Dmpk

Adam J. Rabalski

Associate Director, Chemical Biology

Karsten Thierbach

Executive Director Cmc Biologics

Qing Chen

Senior Director Of Biophysics And Biochemistry

Company overview

Headquarters	United States
Phone number	+15037997520
Website	odysseytx.com
NAICS	541714
Founded	2021
Employees	101-200
Socials

Odyssey Therapeutics Email Formats

Odyssey Therapeutics uses 4 email formats. The most common is {first name} (e.g., john@odysseytx.com), used 76.8% of the time.

Format	Example	Percentage
{first name}	john@odysseytx.com	76.8%
{first initial}.{last name}	j.doe@odysseytx.com	13.4%
{last name}	doe@odysseytx.com	6.2%
{first name}.{last name}	john.doe@odysseytx.com	2.7%

About Odyssey Therapeutics

At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine. In response to recent recruitment fraud, visit our Careers page to verify all job opportunities and read our guidance on this topic: https://odysseytx.com/careers/

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Director

Senior

Employees by Department

Odyssey Therapeutics has 66 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Odyssey Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-05	6	$101,000,000
2025-10-10	7	$213,000,000

Funding Insights

$314,000,000

Total funding amount

$213,000,000

Most recent funding amount

Number of funding rounds

Odyssey Therapeutics Tech Stack

Discover the technologies and tools that power Odyssey Therapeutics's digital infrastructure, from frameworks to analytics platforms.

WP Rocket

Caching

Cloudflare

CDN

Twitter Emoji

Font scripts

Genesis theme

WordPress themes

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Google Tag Manager

Tag managers

GSAP

JavaScript frameworks

Frequently asked questions

Odyssey Therapeutics is located in US.

You can reach Odyssey Therapeutics at +15037997520.

Odyssey Therapeutics generates an estimated annual revenue of $2,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Odyssey Therapeutics has an estimated valuation of $6,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Odyssey Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Odyssey Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Odyssey Therapeutics has raised a total of $314,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Odyssey Therapeutics

Kelly Bourdon

Sr. Director, Clinical Development Operations

Florian Schmidt

Co-Founder And Consultant

Felix Meiß

Co-Founder And Consultant

Camila Serna

Director Of Business Development & Alliance Management

Sebastian Kühner

Executive Director

Stephen Furlong